Cargando…

Mitotic progression following DNA damage enables pattern recognition within micronuclei

Inflammatory gene expression following genotoxic cancer therapy is well documented, yet the events underlying its induction remain poorly understood. Inflammatory cytokines modify the tumor microenvironment by recruiting immune cells and are critical for both local and systemic (abscopal) tumor resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, Shane M, Benci, Joseph L, Irianto, Jerome, Discher, Dennis E, Minn, Andy J, Greenberg, Roger A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857357/
https://www.ncbi.nlm.nih.gov/pubmed/28759889
http://dx.doi.org/10.1038/nature23470
_version_ 1783307456892370944
author Harding, Shane M
Benci, Joseph L
Irianto, Jerome
Discher, Dennis E
Minn, Andy J
Greenberg, Roger A
author_facet Harding, Shane M
Benci, Joseph L
Irianto, Jerome
Discher, Dennis E
Minn, Andy J
Greenberg, Roger A
author_sort Harding, Shane M
collection PubMed
description Inflammatory gene expression following genotoxic cancer therapy is well documented, yet the events underlying its induction remain poorly understood. Inflammatory cytokines modify the tumor microenvironment by recruiting immune cells and are critical for both local and systemic (abscopal) tumor responses to radiotherapy(1). An enigmatic feature of this phenomenon is its delayed onset (days), in contrast to the acute DNA damage responses that occur in minutes to hours. Such dichotomous kinetics implicate additional rate limiting steps that are essential for DNA-damage induced inflammation. Here, we show that cell cycle progression through mitosis following DNA double-strand breaks (DSBs) leads to the formation of micronuclei, which precede activation of inflammatory signaling and are a repository for the pattern recognition receptor cGAS. Inhibiting progression through mitosis or loss of pattern recognition by cGAS-STING impaired interferon signaling. Moreover, STING loss prevented the regression of abscopal tumors in the context of ionizing radiation and immune checkpoint blockade in vivo. These findings implicate temporal modulation of the cell cycle as an important consideration in the context of therapeutic strategies that combine genotoxic agents with immune checkpoint blockade.
format Online
Article
Text
id pubmed-5857357
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-58573572018-03-18 Mitotic progression following DNA damage enables pattern recognition within micronuclei Harding, Shane M Benci, Joseph L Irianto, Jerome Discher, Dennis E Minn, Andy J Greenberg, Roger A Nature Article Inflammatory gene expression following genotoxic cancer therapy is well documented, yet the events underlying its induction remain poorly understood. Inflammatory cytokines modify the tumor microenvironment by recruiting immune cells and are critical for both local and systemic (abscopal) tumor responses to radiotherapy(1). An enigmatic feature of this phenomenon is its delayed onset (days), in contrast to the acute DNA damage responses that occur in minutes to hours. Such dichotomous kinetics implicate additional rate limiting steps that are essential for DNA-damage induced inflammation. Here, we show that cell cycle progression through mitosis following DNA double-strand breaks (DSBs) leads to the formation of micronuclei, which precede activation of inflammatory signaling and are a repository for the pattern recognition receptor cGAS. Inhibiting progression through mitosis or loss of pattern recognition by cGAS-STING impaired interferon signaling. Moreover, STING loss prevented the regression of abscopal tumors in the context of ionizing radiation and immune checkpoint blockade in vivo. These findings implicate temporal modulation of the cell cycle as an important consideration in the context of therapeutic strategies that combine genotoxic agents with immune checkpoint blockade. 2017-07-31 2017-08-24 /pmc/articles/PMC5857357/ /pubmed/28759889 http://dx.doi.org/10.1038/nature23470 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms Reprints and permissions information is available at www.nature.com/reprints (http://www.nature.com/reprints) .
spellingShingle Article
Harding, Shane M
Benci, Joseph L
Irianto, Jerome
Discher, Dennis E
Minn, Andy J
Greenberg, Roger A
Mitotic progression following DNA damage enables pattern recognition within micronuclei
title Mitotic progression following DNA damage enables pattern recognition within micronuclei
title_full Mitotic progression following DNA damage enables pattern recognition within micronuclei
title_fullStr Mitotic progression following DNA damage enables pattern recognition within micronuclei
title_full_unstemmed Mitotic progression following DNA damage enables pattern recognition within micronuclei
title_short Mitotic progression following DNA damage enables pattern recognition within micronuclei
title_sort mitotic progression following dna damage enables pattern recognition within micronuclei
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857357/
https://www.ncbi.nlm.nih.gov/pubmed/28759889
http://dx.doi.org/10.1038/nature23470
work_keys_str_mv AT hardingshanem mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei
AT bencijosephl mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei
AT iriantojerome mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei
AT discherdennise mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei
AT minnandyj mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei
AT greenbergrogera mitoticprogressionfollowingdnadamageenablespatternrecognitionwithinmicronuclei